pre-seed
Stage
2019
Founded
1
Investors
About
Primogene GmbH is a German biotechnology company developing innovative gene therapies for severe genetic diseases. Their lead program focuses on a novel gene therapy for the treatment of Cystic Fibrosis.
Explore Primogene GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.